Balchem Past Earnings Performance
Past criteria checks 5/6
Balchem has been growing earnings at an average annual rate of 7.8%, while the Chemicals industry saw earnings growing at 13% annually. Revenues have been growing at an average rate of 9.6% per year. Balchem's return on equity is 10.6%, and it has net margins of 12.4%.
Key information
7.8%
Earnings growth rate
7.9%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 9.6% |
| Return on equity | 10.6% |
| Net Margin | 12.4% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Balchem makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 930 | 115 | 131 | 16 |
| 31 Dec 23 | 922 | 109 | 130 | 15 |
| 30 Sep 23 | 926 | 103 | 126 | 14 |
| 30 Jun 23 | 941 | 99 | 129 | 13 |
| 31 Mar 23 | 946 | 99 | 126 | 12 |
| 31 Dec 22 | 942 | 105 | 121 | 12 |
| 30 Sep 22 | 923 | 109 | 116 | 14 |
| 30 Jun 22 | 877 | 109 | 109 | 14 |
| 31 Mar 22 | 842 | 102 | 107 | 14 |
| 31 Dec 21 | 799 | 96 | 102 | 14 |
| 30 Sep 21 | 767 | 93 | 100 | 11 |
| 30 Jun 21 | 744 | 90 | 100 | 11 |
| 31 Mar 21 | 715 | 88 | 99 | 10 |
| 31 Dec 20 | 704 | 85 | 102 | 10 |
| 30 Sep 20 | 689 | 83 | 104 | 11 |
| 30 Jun 20 | 673 | 82 | 104 | 11 |
| 31 Mar 20 | 661 | 81 | 102 | 11 |
| 31 Dec 19 | 644 | 80 | 95 | 11 |
| 30 Sep 19 | 641 | 80 | 89 | 12 |
| 30 Jun 19 | 637 | 78 | 84 | 12 |
| 31 Mar 19 | 639 | 78 | 82 | 12 |
| 31 Dec 18 | 644 | 79 | 84 | 12 |
| 30 Sep 18 | 639 | 100 | 83 | 11 |
| 30 Jun 18 | 635 | 97 | 84 | 11 |
| 31 Mar 18 | 618 | 94 | 81 | 10 |
| 31 Dec 17 | 595 | 90 | 81 | 9 |
| 30 Sep 17 | 576 | 64 | 82 | 9 |
| 30 Jun 17 | 564 | 62 | 82 | 8 |
| 31 Mar 17 | 556 | 60 | 82 | 7 |
| 31 Dec 16 | 553 | 56 | 83 | 7 |
| 30 Sep 16 | 545 | 56 | 77 | 7 |
| 30 Jun 16 | 547 | 56 | 76 | 7 |
| 31 Mar 16 | 543 | 56 | 72 | 6 |
| 31 Dec 15 | 552 | 60 | 68 | 6 |
| 30 Sep 15 | 582 | 63 | 71 | 6 |
| 30 Jun 15 | 603 | 64 | 70 | 6 |
| 31 Mar 15 | 600 | 59 | 68 | 5 |
| 31 Dec 14 | 541 | 53 | 57 | 5 |
| 30 Sep 14 | 460 | 45 | 48 | 4 |
| 30 Jun 14 | 387 | 41 | 37 | 4 |
| 31 Mar 14 | 339 | 43 | 30 | 4 |
| 31 Dec 13 | 337 | 45 | 28 | 4 |
| 30 Sep 13 | 336 | 44 | 28 | 3 |
| 30 Jun 13 | 323 | 43 | 28 | 3 |
Quality Earnings: BL9B has high quality earnings.
Growing Profit Margin: BL9B's current net profit margins (12.4%) are higher than last year (10.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BL9B's earnings have grown by 7.8% per year over the past 5 years.
Accelerating Growth: BL9B's earnings growth over the past year (15.8%) exceeds its 5-year average (7.8% per year).
Earnings vs Industry: BL9B earnings growth over the past year (15.8%) exceeded the Chemicals industry -19.4%.
Return on Equity
High ROE: BL9B's Return on Equity (10.6%) is considered low.